返回
刘
刘侃 (Kan Liu)
Department of Respiratory and Critical Care Medicine
35H指数
249论文数
5.5K被引数
收录论文 90
发表时间
Comparative efficacy and safety of lenvatinib, sintilimab combined interventional therapy vs bevacizumab, sintilimab combined interventional therapy in intermediate and advanced hepatocellular carcinoma: a multicenter retrospective study比较仑伐替尼联合信迪利单抗干预疗法与贝伐珠单抗联合信迪利单抗干预疗法在中晚期肝细胞癌中的疗效和安全性:一项多中心回顾性研究

